Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

PharmaMar will commercialize PM1183 with the trade name of Zepsyre™

EurekAlert! - 16 Jun 2017 06:00
(Pharmamar) PharmaMar (PHM:MSE) has announced that PM1183 (lurbinectedin), its third molecule of marine origin and analogue of Yondelis®, will receive the trade name of Zepsyre™.
Full Article at EurekAlert!

More Medical News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard